82 related articles for article (PubMed ID: 28672145)
1. Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock.
Slottosch I; Liakopoulos O; Kuhn E; Scherner M; Deppe AC; Sabashnikov A; Mader N; Choi YH; Wippermann J; Wahlers T
J Crit Care; 2017 Dec; 42():35-41. PubMed ID: 28672145
[TBL] [Abstract][Full Text] [Related]
2. Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study.
Scolari FL; Schneider D; Fogazzi DV; Gus M; Rover MM; Bonatto MG; de Araújo GN; Zimerman A; Sganzerla D; Goldraich LA; Teixeira C; Friedman G; Polanczyk CA; Rohde LE; Rosa RG; Wainstein RV
BMC Cardiovasc Disord; 2020 Nov; 20(1):496. PubMed ID: 33234107
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide levels predict 6-month mortality in patients with cardiogenic shock who were weaned off extracorporeal membrane oxygenation.
Kim HS; Lee KJ; Ha SO; Han SJ; Park KH; Lee SH; Hwang YI; Jang SH; Park S
Medicine (Baltimore); 2020 Jul; 99(29):e21272. PubMed ID: 32702916
[TBL] [Abstract][Full Text] [Related]
4. Survival on Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock: Which Lactate Is Most Useful?
Omar HR; Handshoe JW; Tribble T; Guglin M
ASAIO J; 2022 Jan; 68(1):41-45. PubMed ID: 33769350
[TBL] [Abstract][Full Text] [Related]
5. Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study.
Levy B; Girerd N; Baudry G; Duarte K; Cuau S; Bakker J; Kimmoun A;
Ann Intensive Care; 2024 Mar; 14(1):43. PubMed ID: 38536534
[TBL] [Abstract][Full Text] [Related]
6. Lactate and Lactate Clearance Are Predictive Factors for Mortality in Patients with Extracorporeal Membrane Oxygenation.
Aksoy T; Arslan AH; Ugur M; Ustunsoy H
Braz J Cardiovasc Surg; 2024 Mar; 39(2):e20230091. PubMed ID: 38426430
[TBL] [Abstract][Full Text] [Related]
7. Understanding lactate and its clearance during extracorporeal membrane oxygenation for supporting refractory cardiogenic shock patients.
Kurniawati ER; Weerwind PW; Maessen JG
BMC Cardiovasc Disord; 2023 Jun; 23(1):305. PubMed ID: 37328823
[No Abstract] [Full Text] [Related]
8. ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period.
Banjas N; Hopf HB; Hanisch E; Friedrichson B; Fichte J; Buia A
J Intensive Care; 2018; 6():84. PubMed ID: 30598825
[TBL] [Abstract][Full Text] [Related]
9. Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic Shock.
Jentzer JC; Kashani KB; Wiley BM; Patel PC; Baran DA; Barsness GW; Henry TD; Van Diepen S
Shock; 2022 Jan; 57(1):31-40. PubMed ID: 33988540
[TBL] [Abstract][Full Text] [Related]
10. Peak Blood Lactate at 24 h after ECMO Can Predict 30-day Mortality in Infants after Complex Cardiac Surgery.
Meng F; Li J; Liang W; Dong H; Li B; Qian X; Yang L; Cheng Z
Heart Surg Forum; 2023 Dec; 26(6):E687-E693. PubMed ID: 38178360
[TBL] [Abstract][Full Text] [Related]
11. Comparison of PCO2gap, SvO2 and plasmatic lactate in patients on venoarterial extracorporeal circulation support.
Bezak B; Artemiou P; Ondrusek M; Hulman M
Bratisl Lek Listy; 2024; 125(5):299-304. PubMed ID: 38624054
[TBL] [Abstract][Full Text] [Related]
12. Lactate as a Predictor of 30-Day Mortality in Cardiogenic Shock.
Klemm G; Markart S; Hermann A; Staudinger T; Hengstenberg C; Heinz G; Zilberszac R
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610697
[No Abstract] [Full Text] [Related]
13. Pulsatile ECMO: The Future of Mechanical Circulatory Support for Severe Cardiogenic Shock.
Vincent DE; Moazami N; D'Alessandro D; Fraser JF; Heinsar S; Roche ET; Ayers BC; Singh M; Langer N; Deshpande SR; Jaquiss RDB; Fukamachi K; Rabi SA; Osho A; Kuroda T; Karimov JH; Miyamoto T; Sethu P; Giridharan GA; Kvernebo K; Copland J
JACC Basic Transl Sci; 2024 Apr; 9(4):456-458. PubMed ID: 38680959
[No Abstract] [Full Text] [Related]
14. Mechanical Support in Cardiogenic Shock: The Delicate Balance Between Patient and Machine.
Trêpa M; Walsh MN
JACC Case Rep; 2019 Aug; 1(2):138-140. PubMed ID: 34316770
[No Abstract] [Full Text] [Related]
15. Does lactate clearance prognosticates outcomes in ECMO therapy: a retrospective observational study.
Mungan İ; Kazancı D; Bektaş Ş; Ademoglu D; Turan S
BMC Anesthesiol; 2018 Oct; 18(1):152. PubMed ID: 30355289
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and Oxidative Stress in the Context of Extracorporeal Cardiac and Pulmonary Support.
Hatami S; Hefler J; Freed DH
Front Immunol; 2022; 13():831930. PubMed ID: 35309362
[TBL] [Abstract][Full Text] [Related]
17. Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.
Marbach JA; Di Santo P; Kapur NK; Thayer KL; Simard T; Jung RG; Parlow S; Abdel-Razek O; Fernando SM; Labinaz M; Froeschl M; Mathew R; Hibbert B
J Am Heart Assoc; 2022 Mar; 11(6):e023322. PubMed ID: 35261289
[TBL] [Abstract][Full Text] [Related]
18. Lactate Clearance Is Associated With Improved Survival in Cardiogenic Shock: A Systematic Review and Meta-Analysis of Prognostic Factor Studies.
Marbach JA; Stone S; Schwartz B; Pahuja M; Thayer KL; Faugno AJ; Chweich H; Rabinowitz JB; Kapur NK
J Card Fail; 2021 Oct; 27(10):1082-1089. PubMed ID: 34625128
[TBL] [Abstract][Full Text] [Related]
19. Arterial Lactate Assessment in Cardiogenic Shock: It Is High Time to Beat the Clock.
Rossini R; Ferlini M
JACC Cardiovasc Interv; 2020 Oct; 13(19):2217-2219. PubMed ID: 33032709
[No Abstract] [Full Text] [Related]
20. Arterial Lactate in Cardiogenic Shock: Prognostic Value of Clearance Versus Single Values.
Fuernau G; Desch S; de Waha-Thiele S; Eitel I; Neumann FJ; Hennersdorf M; Felix SB; Fach A; Böhm M; Pöss J; Jung C; Ouarrak T; Schneider S; Werdan K; Zeymer U; Thiele H
JACC Cardiovasc Interv; 2020 Oct; 13(19):2208-2216. PubMed ID: 33032708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]